About: A. David Paltiel

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: A. David Paltiel Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

researcher ORCID ID = 0000-0002-4861-3290

Attributes	Values
rdf:type	Item
description	研究者 (ja) araştırmacı (tr) wetenschapper (nl) дослідник (uk) эрдэмтэн (mn) वैज्ञानिक (hi) изилдөөчү (ky) researcher ORCID ID = 0000-0002-4861-3290 (en)
rdfs:label	A. David Paltiel (en) A. David Paltiel (es) A. David Paltiel (nl) A. David Paltiel (ast)
skos:prefLabel	A. David Paltiel (en) A. David Paltiel (es) A. David Paltiel (nl) A. David Paltiel (ast)
name	A. David Paltiel (en) A. David Paltiel (es) A. David Paltiel (nl) A. David Paltiel (ast)
Scopus author ID	wds:Q58704489-92038CC6-7F12-4ACD-8F22-0C1A135481AA
Scopus author ID	7004306826
given name	wds:Q58704489-EB69E712-2ACF-40A3-9D5A-C32B9C1C762F
given name	A.
instance of	wds:Q58704489-3A3A5F64-BF69-4811-B9FA-8E7B06C22B89
instance of	Homo sapiens
occupation	wds:Q58704489-9EB3A80C-2952-4C77-8FA1-FC9F55597F51
employer	wds:Q58704489-4B27AAD0-0379-49B5-AFFD-18EB67D70C2A
sex or gender	wds:Q58704489-4F165C13-9F96-4181-99A9-05F3BAACB5ED
VIAF ID	wds:Q58704489-3B879948-1CFE-4434-8D7E-CA03EBC9A166
GND ID	wds:Q58704489-b0c881da-3c0a-4c7f-a871-92698d869e12
on focus list of Wikimedia project	wds:Q58704489-25DE53D0-0ECF-46DA-AF88-819315F41388
WorldCat Identities ID (superseded)	wds:Q58704489-C2CF9B59-34F9-4B37-A59F-6A31922BC021
VIAF ID	http://viaf.org/viaf/197294651
GND ID	https://d-nb.info/gnd/171607341
occupation	researcher
employer	Yale School of Public Health
sex or gender	male
VIAF ID	197294651
GND ID	171607341
on focus list of Wikimedia project	WikiProject COVID-19
WorldCat Identities ID (superseded)	viaf-197294651
ORCID iD	wds:Q58704489-4FE95986-DA3A-411B-A85C-E6EDF45013E1
ORCID iD	https://orcid.org/0000-0002-4861-3290
ORCID iD	0000-0002-4861-3290
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q58704489
is author of	Racial and sex disparities in life expectancy losses among HIV-infected persons in the united states: impact of risk behavior, late initiation, and early discontinuation of antiretroviral therapy. Prophylaxis for human immunodeficiency virus-related Pneumocystis carinii pneumonia: using simulation modeling to inform clinical guidelines The cost-effectiveness of preventing AIDS-related opportunistic infections The survival benefits of AIDS treatment in the United States Placing a price on medical device innovation: the example of total knee arthroplasty. Cost-effectiveness of total knee arthroplasty in the United States: patient risk and hospital volume. Scaling up antiretroviral therapy in South Africa: the impact of speed on survival State AIDS Drug Assistance Programs: equity and efficiency in an era of rapidly changing treatment standards. The cost effectiveness of combination antiretroviral therapy for HIV disease. Dengue vector control strategies in an urban setting: an economic modelling assessment Conceptualizing a model: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force--2. Scaling up circumcision programs in Southern Africa: the potential impact of gender disparities and changes in condom use behaviors on heterosexual HIV transmission Newer drugs and earlier treatment: impact on lifetime cost of care for HIV-infected adults Lifetime cost of HIV care in France during the era of highly active antiretroviral therapy. Cost-effectiveness of nonsteroidal anti-inflammatory drugs and opioids in the treatment of knee osteoarthritis in older patients with multiple comorbidities Disease-modifying drugs for knee osteoarthritis: can they be cost-effective? Forced expiratory volume in 1 second percentage improves the classification of severity among children with asthma. A single measure of FEV1 is associated with risk of asthma attacks in long-term follow-up. FEV1 is associated with risk of asthma attacks in a pediatric population Cost-effectiveness of genotype testing for primary resistance in Brazil Cost-effectiveness of HIV treatment as prevention in serodiscordant couples Incidence of primary opportunistic infections in two human immunodeficiency virus-infected French clinical cohorts Model parameter estimation and uncertainty: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force--6 HIV preexposure prophylaxis in the United States: impact on lifetime infection risk, clinical outcomes, and cost-effectiveness Cost-Effectiveness of Community-Based TB/HIV Screening and Linkage to Care in Rural South Africa Economic costs of influenza-related work absenteeism. Economic savings versus health losses: the cost-effectiveness of generic antiretroviral therapy in the United States Model parameter estimation and uncertainty analysis: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force Working Group-6 Test and treat DC: forecasting the impact of a comprehensive HIV strategy in Washington DC Expanded HIV screening in the United States: effect on clinical outcomes, HIV transmission, and costs. Expanded screening for HIV in the United States--an analysis of cost-effectiveness. Projecting the cost-effectiveness of adherence interventions in persons with human immunodeficiency virus infection Cost-effectiveness of an intervention to improve adherence to antiretroviral therapy in HIV-infected patients Impact of obesity and knee osteoarthritis on morbidity and mortality in older Americans Cost-effectiveness of preventing loss to follow-up in HIV treatment programs: a Côte d'Ivoire appraisal Surveillance for isocyanate asthma: a model based cost effectiveness analysis Routine HIV screening in France: clinical impact and cost-effectiveness Lifetime medical costs of knee osteoarthritis management in the United States: impact of extending indications for total knee arthroplasty HIV cure strategies: how good must they be to improve on current antiretroviral therapy? A therapeutic HIV vaccine: how good is good enough? Mobile HIV screening in Cape Town, South Africa: clinical impact, cost and cost-effectiveness Cost-effectiveness of HIV testing and treatment in the United States The cost-effectiveness of pre-exposure prophylaxis for HIV infection in South African women Cost-effectiveness of canine vaccination to prevent human rabies in rural Tanzania Dengue dynamics and vaccine cost-effectiveness in Brazil. The cost-effectiveness of rapid HIV testing in substance abuse treatment: results of a randomized trial Mathematical programming for the efficient allocation of health care resources. Predicting the impact of a partially effective HIV vaccine and subsequent risk behavior change on the heterosexual HIV epidemic in low- and middle-income countries: A South African example. Optimal frequency of CD4 cell count and HIV RNA monitoring prior to initiation of antiretroviral therapy in HIV-infected patients Scaling up the 2010 World Health Organization HIV Treatment Guidelines in resource-limited settings: a model-based analysis When to start antiretroviral therapy in resource-limited settings Cost-effectiveness of omalizumab in adults with severe asthma: results from the Asthma Policy Model A novel approach to defining the relationship between lung function and symptom status in asthma

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 188 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software